It targets MNC, a transcriptional repressor of the oncogene c-Myc, and promotes its function in hypoxic conditions to increase melanoma proliferation and survival and can also act as an immunosuppressant against cytotoxic T lymphocytes [123,124]. Here, MYC is linked to melanoma.